Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,581 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients.
Hirakata H, Tsubakihara Y, Gejyo F, Nishi S, Iino Y, Watanabe Y, Suzuki M, Saito A, Akiba T, Inaguma D, Fukuhara S, Morita S, Hiroe M, Hada Y, Suzuki M, Akaishi M, Aonuma K, Akizawa T. Hirakata H, et al. Among authors: saito a. Clin Exp Nephrol. 2010 Feb;14(1):28-35. doi: 10.1007/s10157-009-0212-4. Epub 2009 Sep 9. Clin Exp Nephrol. 2010. PMID: 19763743 Clinical Trial.
Positive outcomes of high hemoglobin target in patients with chronic kidney disease not on dialysis: a randomized controlled study.
Akizawa T, Gejyo F, Nishi S, Iino Y, Watanabe Y, Suzuki M, Saito A, Akiba T, Hirakata H, Fukuhara S, Morita S, Hiroe M, Hada Y, Suzuki M, Akaishi M, Iwasaki M, Tsubakihara Y; KRN321 STUDY Group. Akizawa T, et al. Among authors: saito a. Ther Apher Dial. 2011 Oct;15(5):431-40. doi: 10.1111/j.1744-9987.2011.00931.x. Epub 2011 May 25. Ther Apher Dial. 2011. PMID: 21974695 Clinical Trial.
Low hemoglobin levels and hypo-responsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients.
Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T, Hirakata H, Watanabe Y, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y; JET Study Group. Akizawa T, et al. Among authors: saito a. Ther Apher Dial. 2014 Oct;18(5):404-13. doi: 10.1111/1744-9987.12155. Epub 2014 Feb 25. Ther Apher Dial. 2014. PMID: 24571446
Impacts of recombinant human erythropoietin treatment during predialysis periods on the progression of chronic kidney disease in a large-scale cohort study (Co-JET study).
Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T, Hirakata H, Watanabe Y, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y; Co-JET Study Group. Akizawa T, et al. Among authors: saito a. Ther Apher Dial. 2014 Apr;18(2):140-8. doi: 10.1111/1744-9987.12066. Epub 2013 Aug 27. Ther Apher Dial. 2014. PMID: 24720404
Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST).
Saito O, Kusano E, Akimoto T, Asano Y, Kitagawa T, Suzuki K, Ishige N, Akiba T, Saito A, Ishimura E, Hattori M, Hishida A, Guili C, Maruyama H, Kobayashi M, Ohashi T, Matsuda I, Eto Y. Saito O, et al. Among authors: saito a. Clin Exp Nephrol. 2016 Apr;20(2):284-93. doi: 10.1007/s10157-015-1146-7. Epub 2015 Jul 22. Clin Exp Nephrol. 2016. PMID: 26197777
Effect of Predialysis Recombinant Human Erythropoietin on Early Survival After Hemodialysis Initiation in Patients With Chronic Kidney Disease: Co-JET Study.
Watanabe Y, Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T, Hirakata H, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y; Co-JET Study Group. Watanabe Y, et al. Among authors: saito a. Ther Apher Dial. 2016 Dec;20(6):598-607. doi: 10.1111/1744-9987.12425. Epub 2016 Dec 7. Ther Apher Dial. 2016. PMID: 27928910
4,581 results